Market LIVE
Published markets; coverage varies by country
Product profile · United States

LUTATHERA

 ·  Patent Litigation & Settlement History ↓

IngredientLUTETIUM LU 177 DOTATATE
Application typeNDA
Application208700
Product001
Dosage formSOLUTION
RouteINTRAVENOUS
Strength10mCi/ML
Approval date2018-01-26
Marketing statusPrescription
Status event—
ApplicantAAA USA INC
Product source

Current GenericRadar decision

Year2026
SelectionEXISTING_GENERIC
ReviewFINAL
Anchor typeEXISTING_GENERIC
Anchor date2026-09-21
Patent anchor—
Exclusivity anchor2025-07-26
Protection date—
First Final ANDA2026-09-21
Status event2026-09-21

GNR judgment: EXISTING_GENERIC. Reference year: 2026. Anchor type: EXISTING_GENERIC. Patent anchor: not recorded. Exclusivity anchor: 2025-07-26. Anchor date: 2026-09-21. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
105962762038-07-25DP ————
———
105962782038-07-25DP ————
———
119040272038-07-25DP ————
———
121448732038-07-25U U-4036———
———
121510032038-07-25DP/U U-4036———
———
121617322038-07-25DP/U U-4036———
———
121680632038-07-25DP/U U-4036———
———
124150032038-07-25U U-4036———
———
124912722038-07-25U U-4036———
———
105962762039-01-25— ————
—2039-01-25—
105962782039-01-25— ————
—2039-01-25—
119040272039-01-25— ————
—2039-01-25—
121448732039-01-25— ————
—2039-01-25—
121510032039-01-25— ————
—2039-01-25—
121617322039-01-25— ————
—2039-01-25—
121680632039-01-25— ————
—2039-01-25—
124150032039-01-25— ————
—2039-01-25—
124912722039-01-25— ————
—2039-01-25—

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NPP—2027-04-23————Source
PED—2027-10-23————Source
ODE-479—2031-04-23————Source
PED—2031-10-23————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
217060 / 001APPLICATION_FINAL_OBSERVATION · FINAL_PRODUCT_DATE_UNVERIFIED——LANTHEUS MEDICALNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource
217060 / 001FINAL_APPROVAL · FINAL_APPROVED2026-09-21—LANTHEUS MEDICALNEXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 1 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
217060 / 001LANTHEUS MEDICALFINAL_APPROVAL · FINAL_APPROVED2026-09-21 EXACT_PRODUCT · EXACT_PRODUCT_VERIFIEDSource—
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.